These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 27941051)

  • 1. Vascular risk in obesity: Facts, misconceptions and the unknown.
    King RJ; Ajjan RA
    Diab Vasc Dis Res; 2017 Jan; 14(1):2-13. PubMed ID: 27941051
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Endothelial dysfunction in obesity: etiological role in atherosclerosis.
    Meyers MR; Gokce N
    Curr Opin Endocrinol Diabetes Obes; 2007 Oct; 14(5):365-9. PubMed ID: 17940464
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Adipokines at the crossroad between obesity and cardiovascular disease.
    Molica F; Morel S; Kwak BR; Rohner-Jeanrenaud F; Steffens S
    Thromb Haemost; 2015 Mar; 113(3):553-66. PubMed ID: 25338625
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Weight Loss and the Prevention and Treatment of Type 2 Diabetes Using Lifestyle Therapy, Pharmacotherapy, and Bariatric Surgery: Mechanisms of Action.
    Grams J; Garvey WT
    Curr Obes Rep; 2015 Jun; 4(2):287-302. PubMed ID: 26627223
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The progression of cardiovascular risk to cardiovascular disease.
    Rosin BL
    Rev Cardiovasc Med; 2007; 8 Suppl 4():S3-8. PubMed ID: 17934392
    [TBL] [Abstract][Full Text] [Related]  

  • 6. New vistas for the treatment of obesity: turning the tide against the leading cause of morbidity and cardiovascular mortality in the developed world.
    Lepor NE; Fouchia DD; McCullough PA
    Rev Cardiovasc Med; 2014; 15 Suppl 2():S1-19; quiz S20-1. PubMed ID: 25662755
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Pharmacological therapy of obesity].
    Pagotto U; Vanuzzo D; Vicennati V; Pasquali R
    G Ital Cardiol (Rome); 2008 Apr; 9(4 Suppl 1):83S-93S. PubMed ID: 18773755
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Obesity and the skin.
    Shipman AR; Millington GW
    Br J Dermatol; 2011 Oct; 165(4):743-50. PubMed ID: 21564065
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pharmacological and non-pharmacological interventions to influence adipose tissue function.
    Westerink J; Visseren FL
    Cardiovasc Diabetol; 2011 Jan; 10():13. PubMed ID: 21276223
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The multiple facets of the fat tissue.
    Rocha VZ; Libby P
    Thyroid; 2008 Feb; 18(2):175-83. PubMed ID: 18279018
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Therapeutic options for metabolic syndrome in obese patients].
    Carella AM; Conte M
    Clin Ter; 2007; 158(5):457-64. PubMed ID: 18062354
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cardiovascular benefits of bariatric surgery.
    Lee GK; Cha YM
    Trends Cardiovasc Med; 2016 Apr; 26(3):280-9. PubMed ID: 26776254
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Targeting MCP-1 to reduce vascular complications of obesity.
    Ohman MK; Eitzman DT
    Recent Pat Cardiovasc Drug Discov; 2009 Nov; 4(3):164-76. PubMed ID: 19925437
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Obesity and Liver Cancer.
    Aleksandrova K; Stelmach-Mardas M; Schlesinger S
    Recent Results Cancer Res; 2016; 208():177-198. PubMed ID: 27909908
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Role of white adipose tissue in vascular complications due to obesity].
    Gómez-Hernández A; Perdomo L; Escribano Ó; Benito M
    Clin Investig Arterioscler; 2013; 25(1):27-35. PubMed ID: 23522279
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Drug treatments to restore vascular function and diabesity.
    Cardillo C
    Ann Pharm Fr; 2013 Jan; 71(1):27-33. PubMed ID: 23348853
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Body fat mass distribution. Influence on metabolic and atherosclerotic parameters in non-insulin dependent diabetics and obese subjects with and without impaired glucose tolerance. Influence of weight reduction.
    Van Gaal L
    Verh K Acad Geneeskd Belg; 1989; 51(1):47-80. PubMed ID: 2800685
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of obesity and subsequent weight reduction on left ventricular function.
    Lakhani M; Fein S
    Cardiol Rev; 2011; 19(1):1-4. PubMed ID: 21135595
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Precision Medicine in Weight Loss and Healthy Living.
    Severin R; Sabbahi A; Mahmoud AM; Arena R; Phillips SA
    Prog Cardiovasc Dis; 2019; 62(1):15-20. PubMed ID: 30610881
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Treatment of the obese patient in primary care: targeting and meeting goals and expectations.
    Bray G; Look M; Ryan D
    Postgrad Med; 2013 Sep; 125(5):67-77. PubMed ID: 24113665
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.